Clinical Evaluation of the Photoallergy Potential of Atralin Gel

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Coria Laboratories, Ltd.
• Treatments: Tretinoin

Criteria

Inclusion Criteria:

• Normal, healthy volunteers

• 18 years of age and older

Exclusion Criteria:

• Less than 18 years of age